Form 4: Sabra Health Care REIT Director Acquires Shares Through Dividend Equivalent Payments

Director Jeffrey A. Malehorn acquired 1,011 shares of Sabra Health Care REIT, Inc. common stock due to dividend equivalent payments on previously granted stock units.

Summary

• On May 31, 2024, Jeffrey A. Malehorn, a director of Sabra Health Care REIT, Inc., acquired 1,011 shares of common stock.
• The acquisition was a result of dividend equivalent payments on stock units previously granted to Malehorn under the company's 2009 Performance Incentive Plan.
• The price per share for the acquisition is listed as $0, indicating it was not a direct purchase but rather a dividend equivalent.
• Following the transaction, Malehorn beneficially owns 83,584 shares of Sabra Health Care REIT, Inc. common stock, which includes 1,035 unvested stock units and 49,070 stock units that have vested but the payment of which has been deferred.
• Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transaction is a routine part of executive compensation and doesn't indicate any significant positive or negative development for the company.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This type of transaction is common for executives and directors who receive stock-based compensation. It reflects ongoing compensation and alignment with shareholder interests.

Comparison to Industry Standards

• Stock unit grants and dividend equivalent payments are standard compensation practices in REITs and other publicly traded companies.
• Comparing the size of the stock unit grants and the terms of the vesting schedule to those of peer companies (e.g., Welltower, Ventas, Healthpeak Properties) would provide a better understanding of the competitiveness of Sabra's executive compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.

Key Dates